arrow
F

Flavio Ribichini

university of verona
H指数:47
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Red blood cell distribution width and blood transfusions are associated with 2-year mortality after transcatheter aortic valve implantation in males but not in females: sex-related differences in hematological predictors

红细胞分布宽度与输血与男性经导管主动脉瓣置入术后的2年死亡率相关,但与女性无关:性别相关的血液学预测因子差异

2026-02-220
PRE
Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial

生理学 vs 血管造影引导的经皮冠状动脉介入治疗在经导管主动脉瓣植入术中的应用:FAITAVI 研究

2025-12-011
PRE
Rationale and design of REAC-TAVI 2: single antiplatelet treatment with ticagrelor versus aspirin after transcatheter aortic valve implantation

RATIONALE AND DESIGN OF REAC-TAVI 2:经导管主动脉瓣植入术后替格瑞洛单药抗血小板治疗与阿司匹林比较的方案与设计

2025-11-010
PRE
Indications for Use of Drug-Coated Balloons in Coronary Intervention

药物涂层球囊在冠状动脉介入治疗中的应用指征

JACC
IF0
2025-10-060
PRE
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium

Fezzi, S.; Scheller, B.; Cortese, B.; Alfonso, F.; Jeger, R.; Colombo, A.; Joner, M.; Shin, E.S.; Kleber, F.X.; Latib, A.; 等. 药物涂层球囊在冠状动脉疾病中的应用:定义和标准化终点——药物涂层球囊学术研究联盟共识文件。EuroIntervention 2025, 21, e1116–e1136. [Google Scholar] [CrossRef]

2025-10-014
PRE
Drug-coated balloons for coronary bifurcation lesions

药物涂层球囊用于冠状动脉分叉病变

2025-10-010
PRE
Reply to “Transaortic Flow Rate and Risk Stratification in Moderate Aortic Stenosis - From Ventricle to Vasculature”

回复“经主动脉血流量与中度主动脉瓣狭窄的风险分层——从心室到血管”

2025-09-160
PRE
A New Look for Micra: Epicardial Use of a Modified Micra-Based Pediatric IPG in a Neonate With Complete Heart Block

Micra的新型应用:改良型基于Micra的儿科植入式起搏器(IPG)在完全性心脏传导阻滞新生儿中的心外膜应用

2025-09-010
PRE